Health & Social Care
47mentions · last 12 months↓
View full analysis →This Lords select committee scrutinises childhood vaccination policy, uptake rates, and delivery mechanisms across the UK health system. The committee operates in the House of Lords and conducts formal inquiries, taking oral evidence from witnesses including NHS representatives, public health experts, and community stakeholders. Its investigation focuses on identifying and addressing barriers to vaccination coverage among priority populations. Recent sessions have examined GP-led vaccination programmes and their effectiveness in improving uptake, explored disparities in vaccine access and uptake within Traveller and Somali communities, and reviewed broader NHS data collection and delivery challenges affecting childhood vaccination programmes across the UK. The committee has also assessed how vaccination services reach families in underserved areas and the role of different service delivery models in narrowing health inequalities.
11 sessions published in the last 12 months
Click any cell in the heatmap to see the sessions held that day and the insights extracted from them.
187 insights
06 Jul 2026
The committee scrutinised the Government’s response to falling childhood vaccination rates in England, especially inequalities in deprived areas and the effects of NHS reorganisation. The Minister for Public Health and Prevention said immunisation is a tier-1 priority, committed to report progress to Parliament if the committee recommends it, and set out a strategy based on access, accountability, digital/data, and communication. Officials confirmed changes to GP incentives, the move to ICB-led commissioning from 2027, the rollout of MAVIS and other digital systems, and a stronger role for schools, DfE, UKHSA and neighbourhood health teams. The witnesses also acknowledged persistent problems: fragmented messaging, variable school participation, workforce shortages, weak data flows, and the need for better local outreach and anti-misinformation work.
29 Jun 2026
The committee examined progress on the 2023 NHS vaccination strategy and the 2025 UKHSA immunisation equity strategy, focusing on delegated responsibility to ICBs, the adequacy and targeting of outreach funding, inconsistent use of quality standards and training, and the need for better data and clearer accountability. NHS England said the strategy is progressing but has no separate dedicated budget, with £13 million a year for outreach and local prioritisation within existing envelopes. UKHSA stressed that public health leadership, local expertise, joined-up communications, better data flows and denominator cleaning, and more coherent training and assurance are needed to reduce inequalities and improve childhood vaccination uptake.
22 Jun 2026
The committee examined why childhood vaccination coverage is recovering unevenly after Covid, with WHO evidence showing the UK is above the global DTP3 target but still below the European regional target. Witnesses highlighted the main barriers as access, inequity, data limitations, and trust/misinformation, while stressing that school-entry checks, targeted outreach, better registries and consistent communication can improve uptake. MHRA and JCVI set out the safety, licensing and surveillance framework for routine vaccines, defended the benefit-risk balance, and said changes to schedules should remain evidence-led, with mandatory vaccination described by WHO as a last-resort option rather than a default policy.
15 Jun 2026
The committee scrutinised how England can reverse declining childhood vaccination coverage, especially MMR, and reduce stark inequalities. Witnesses from public health and primary care argued for a stronger national 95% target, clearer accountability across national, regional and local levels, and a sustained focus on deprivation, workforce capacity and access. Professor Sir Andrew Pollard explained vaccine safety, licensing and post-marketing surveillance, but said public communication is often poor and that uptake problems are driven mainly by access and local barriers rather than simple hesitancy. There was broad agreement on the need for better data, locally embedded outreach, and more vaccine-literate communication through schools and communities.
01 Jun 2026
The committee scrutinised how childhood vaccination coverage is delivered and measured through pharmacies, school immunisation services, CHIS, GP systems and NHS data infrastructure. Witnesses argued that pilots should prove feasibility rather than benefit, called for more consistent national commissioning and funding, and highlighted outreach, school access and workforce costs as major constraints. On data, witnesses said the system is too fragmented, with manual transfers, incomplete denominators, weak interoperability and inconsistent data-sharing rules undermining surveillance, outbreak response and equity. The panel repeatedly pressed for automated transfers, a clearer national specification, better linkage between systems, and stronger cross-departmental working, especially with DHSC, NHS England, UKHSA and the Department for Education.
27 Apr 2026
The session scrutinised trends and disparities in school-aged vaccination uptake in England, focusing on post-COVID declines, drivers, and responsibility for improving coverage. Witnesses highlighted an overall downward uptake with about 3% antivaccine activity and significant hesitancy, widening inequalities, and challenges in reaching home-educated or looked-after children. They stressed a whole-system approach involving schools, commissioners, GPs, and immunisation teams, and called for evergreen catch-up, MECC, and better data interoperability (GP records, local health information systems, and the NHS app). They argued for more accessible delivery channels (GPs, pharmacies, school-based sessions, and targeted outreach via schools) and for strengthening communications, PSHE inclusion, and resource/financing models to sustain vaccination programmes. They flagged potential changes under new ICB structures and urged dedicated immunisation services, enhanced data sharing, and flexible commissioning to address health inequalities and improve uptake.
29 Jun 2026